Results 241 to 250 of about 10,682,507 (345)
From friend to foe and back: coevolutionary transitions in the mutualism-antagonism continuum. [PDF]
Proc Biol SciJäger F, Schurr FM, Allhoff KT.
europepmc +1 more source
Molecular Oncology, EarlyView.A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul +11 more
wiley +1 more source
Experimental and numerical simulation studies on the mechanical properties and failure characteristics of rock masses with weak interlayers. [PDF]
PLoS OneWang F +8 more
europepmc +1 more source
Recent progress in the study of variation, heredity, and evolution, by Robert Heath Lock ...
, 1906 Robert Heath Lock
openalex +2 more sources
Molecular Oncology, EarlyView.Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva +5 more
wiley +1 more source
Molecular Oncology, EarlyView.Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef +10 more
wiley +1 more source
Temporal power of a cycling sprinter: experiments and effective time theory. [PDF]
Proc Biol SciClanet C +7 more
europepmc +1 more source
The theory of evolution : with special reference to the evidence upon which it is founded
, 1917 W. B. Scott
openalex +2 more sources